Integrated personalized diabetes management goes Europe

Project acronym: iPDM-GO

Integrated personalized diabetes management (iPDM) is an iterative process shown to improve outcomes, treatment satisfaction and patient adherence. iPDM-GO will build on these results and realise iPDM in Denmark, enhancing it through a digital patient assessment tool and exploring predictive modelling approaches. The digital tool will help healthcare professionals and people with type 2 diabetes pinpoint the most appropriate intervention strategies and facilitate shared decision making.

iPDM-GO

Partners
Roche Diagnostics GmbH, Profil Institut für Stoffwechselforschung GmbH, Aberystwyth University, Capital Region of Denmark, Helmholtz Zentrum München Deutsches Forschungszentrum Fuer Gesundhelt und Umwelt GMBH, City of Copenhagen (Københavns Kommune), Danmarks Tekniske Universitet, LINQ management GmbH, Region Sjælland

UCPH Budget
€ 362,043

UCPH Partner
Prof. Karsten Vrangbæk, Dept. of Public Health, Prof. Timothy Skinner, Dept. of Psychology

Co-branding-logo

This activity has received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union's Horizon 2020 research and innovation programme.